Status: Recruiting
R-CDOP Regimen in the Treatment of Newly Diagnosed Non-Hodgkin's Lymphoma With High Tumor Burden
A single-center, prospective clinical study to evaluate the efficacy and safety of R-CDOP (Rituximab, Cyclophosphamide, Doxorubicin hydrochloride liposome, Vindesine, Prednisone ) in the treatment of newly diagnosed high tumor burden non-Hodgkin's lymphoma, which has previously shown promising efficacy.
Participants needed: 64
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: oubai, MD/PhDUpdated: Sep 16, 2021Locations: 1
Eligibility criteria
Histologically immunohistochemistry and imaging confirmed diffuse large B-cell l... [+9]
Pregnant or lactation and patients of childbearing age who do not want to take c... [+9]